Molecular biomarkers represent one of the most significant advancements in biochemistry and modern medicine. They are measurable biological molecules found in blood, tissues, or other body fluids that indicate the presence or progression of a specific disease. The discovery of biomarkers has transformed diagnostic strategies, particularly for chronic and life-threatening conditions such as cancer, cardiovascular diseases, and genetic disorders. The concept of biomarkers is based on the fact that cellular dysfunction leads to measurable changes in gene expression, protein production, or enzyme activity. These molecular alterations can be detected using advanced biochemical techniques, enabling disease identification even before clinical symptoms appear. Common examples include cardiac troponin for diagnosing heart attacks, C-reactive protein as an indicator of inflammation, and various tumor markers used in cancer monitoring and treatment evaluation. DNA and RNA analyses are also applied to detect genetic mutations associated with inherited diseases. Measurement of molecular biomarkers requires highly sensitive techniques such as immunoassays, polymerase chain reaction, and modern spectrometric methods. These analyses are performed in specialized laboratories equipped with strict quality control systems to ensure reliability and accuracy. Biomarkers play a crucial role in personalized medicine, where treatment plans are tailored according to the molecular profile of each patient. They also assist in monitoring disease progression and assessing therapeutic effectiveness, ultimately improving patient outcomes. Despite their importance, biomarker applications require extensive clinical validation to confirm sensitivity and specificity, along with advanced instrumentation and well-trained laboratory professionals.